ÀÇÎѵ¼º½

Dr. William C. Huang says the agent could be a paradigm-changing method of treating some bladder cancers.

A new study shows that combining mRNA and pembrolizumab creates a vaccine effective against melanoma.

More than 70 percent of people in the clinical trial responded to the drug.

The PRECEDE Consortium aims to increase the 5-year survival rate to 50 percent within the next 10 years.

Advances in drug design are making gains against a difficult to treat cancer.

Dr. Nina D’Abreo says people should expect one-on-one care when they seek treatment with her.

Dr. Michael Shusterman says monitoring ctDNA is one way to determine who can forgo additional treatment.

Dr. Nancy Chan shares advances in targeted therapies for breast cancer that progressed after hormone therapy.

Antibody signatures are found to predict treatment success for two leading checkpoint inhibitors.

Dr. David J. Byun says the role and optimal duration of hormone therapy continue to remain controversial.